Gemcitabine combination therapies induce apoptosis in uterine carcinosarcoma patient-derived organoids

In conclusion, for the UCS1 patient-derived tumor cells, gemcitabine combinations were more effective than carboplatin/paclitaxel. Our data support the use of PDOs to predict responses to second-line chemotherapy.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research